Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

UConn: Repeats influence genome biology

About 50% of human DNA today is made of duplicated sequences that are the remnants of transposition events that took place in our evolutionary history....

| By Kelley Gipson

Bayer and Azitra collaborate on skin bacteria

Bayer and Azitra have announced a joint development agreement to collaborate in the identification and characterization of skin microbiome bacteria. The partnership will leverage Azitra’s...

| By Kelley Gipson

SpringWorks collaborates with Allogene re myeloma

SpringWorks Therapeutics has entered into a clinical trial collaboration agreement with Allogene Therapeutics.. This agreement will evaluate ALLO-715, Allogene’s investigational anti-B-cell maturation antigen (BCMA) AlloCAR...

| By Kelley Gipson

CBX-12 is Cybrexa’s new lead development program

Cybrexa Therapeutics has announced CBX-12 (alphalexTM-exatecan) as its new lead development program. CBX-12 is an alphalexTM conjugate that includes the highly potent topoisomerase I inhibitor exatecan. CBX-12...

| By Kelley Gipson

IsoPlexis pulls in additional $20M funding

IsoPlexis has raised an additional $20 million in its Series C financing, bringing the entire Series C round to $45 million. The funding will continue to...

| By Kelley Gipson

ReNetX gets Fast Track for spinal cord treatment

ReNetX Bio reports that the FDA has granted the company Fast Track Designation for ReNetX Bio’s clinical therapy (AXER-204) for the potential treatment of Chronic Spinal...

| By Kelley Gipson

Thetis 2019 recap and 2020 outlook

Gary Mathias, Co-Founder and CEO of Thetis Pharmaceuticals, recently shared the following message. Happy New Year from the Thetis team! I am glad to report...

| By Kelley Gipson

ABCT announces 2020 life sciences cohort

ABCT, the Accelerator for Biosciences in Connecticut, has announced the second cohort of emerging biosciences ventures invited to participate in its annual program. The 2020 ABCT cohort...

| By Kelley Gipson

CTNext mentor network applications due 1/15

CTNext is looking for startup companies that are poised for growth, but need access to some specialized, quality expertise to accelerate to the next level....